Study protocol for Adaptive ChemoTherapy for Ovarian cancer (ACTOv) - a multicentre phase II randomised controlled trial to evaluate adaptive therapy efficacy
Favorite
Share
More Options
Fullscreen
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
